ANGO financials
AngioDynamics (ANGO) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
ANGO income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2026 | $320.17M | $174.89M | -$39.93M | -$36.74M | -0.88 |
| 2025 | $292.50M | $157.71M | -$39.95M | -$33.99M | -0.83 |
| 2024 | $303.91M | $154.70M | -$192.44M | -$184.35M | -4.59 |
| 2023 | $338.75M | $174.25M | -$51.18M | -$52.44M | -1.33 |
| 2022 | $316.22M | $165.73M | -$28.47M | -$26.55M | -0.68 |
| 2021 | $291.01M | $156.79M | -$35.28M | -$31.55M | -0.82 |
- ANGO revenue was $320.17M in fiscal 2026, net income -$36.74M.
Updated 2026-11-05 12:51 UTC